Chest Drainage Catheters - Market Insights, Competitive Landscape, and Market Forecast - 2032

Chest Drainage Catheters Market by Product Type (Thoracic Catheters, Pleural Drainage Catheters, Trocar Catheters, and Others), Material (Silicone, PVC (Polyvinyl Chloride), and Others), Application (Cardiothoracic Surgery, Pleural Effusion, Trauma Surgery, Pneumothorax, and Others), End-User (Hospitals, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World) is expected to grow at a steady CAGR forecast till 2032 owing to the rising instances of chronic disorders and increased adoption of minimally invasive, digital, and image-guided procedures across the world.

The chest drainage catheters market is estimated to grow at a CAGR of 4.78% during the forecast period from 2025 to 2032. The demand for chest drainage catheters is being driven by several critical factors, including the rising global prevalence of chronic conditions such as cancer, cardiovascular diseases, malignant pleural effusions, pneumothorax, hemothorax, and pericardial effusions, all of which frequently require thoracic drainage interventions. The growing burden of these conditions, along with advancements in catheter technology, increased healthcare access, and continued product innovation by key market players, is creating a supportive environment for market expansion. Collectively, these factors are propelling demand and reinforcing the critical role of chest drainage catheters in modern clinical care during the forecast period from 2025 to 2032.

Chest Drainage Catheters Market Dynamics:

According to data from the International Agency for Research on Cancer (2024), in the year 2022, there were 24,80,675 reported cases of Trachea, bronchus, and lung cancer. Out of which Asia accounted for 63.1% of all the cases.

These types of cancers, particularly lung are often associated with recurrent pleural effusions, a condition managed using tunneled or non-tunneled chest drainage catheters for palliative and therapeutic care. The growing cancer burden, especially in advanced-stage disease, is directly increasing the demand for such catheter systems across hospitals, oncology centers, and home care settings.

In addition to oncology, the prevalence of cardiovascular diseases is also a significant driver. According to the British Heart Foundation (2024), approximately 620 million people globally were living with heart and circulatory diseases, and 1 in 13 individuals worldwide was affected by such conditions. Cardiovascular events, such as heart attacks and cardiac surgeries, frequently result in pericardial effusions or postoperative fluid accumulation, necessitating the use of closed-system chest drainage catheters to prevent cardiac tamponade and promote recovery.

Furthermore, the increased adoption of minimally invasive, digital, and image-guided procedures is significantly boosting the chest drainage catheter market by enhancing procedural precision, patient safety, and recovery outcomes. Minimally invasive techniques reduce trauma, lower the risk of infection, and shorten hospital stays, making them highly preferred by both clinicians and patients. Image-guided catheter placements especially those using ultrasound or fluoroscopy enable accurate positioning, minimizing complications such as tissue damage or malposition. Digital innovations, such as smart catheters equipped with flow sensors and pressure monitors, are enabling real-time drainage monitoring, early detection of complications, and better postoperative management. These advancements not only improve clinical efficiency and patient outcomes but also align with global healthcare trends favoring outpatient care and cost-effective solutions.

Therefore, the increasing global burden of cancer and heart disease is driving the need for safe, effective, and minimally invasive thoracic drainage solutions, which in turn is expected to significantly boost the growth of the chest drainage catheters market during the forecast period from 2025 to 2032.

However, the complexity and limitations associated with chest drainage catheters, and stringent regulatory requirements, among others are some of the key constraints that may limit the growth of the chest drainage catheters market.

Chest Drainage Catheters Market Segment Analysis:

Product Type (Thoracic Catheters, Pleural Drainage Catheters, Trocar Catheters, and Others), Material (Silicone, PVC (Polyvinyl Chloride), and Others), Application (Cardiothoracic Surgery, Pleural Effusion, Trauma Surgery, Pneumothorax, and Others), End-User (Hospitals, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the product type segment of the chest drainage catheters market, the pleural drainage catheters category is estimated to account for the largest market share in 2024. Pleural drainage catheters are significantly boosting the overall chest drainage catheter market due to their growing use in the management of pleural effusions, pneumothorax, hemothorax, and other thoracic conditions requiring fluid or air evacuation from the pleural cavity. With the rising incidence of pleural diseases often linked to lung cancer, congestive heart failure, infections, and trauma the demand for pleural drainage solutions has increased steadily across both acute care and long-term care settings.

These catheters, especially tunneled indwelling pleural catheters (TIPCs) such as the PleurX(TM) system, have become the preferred solution for managing recurrent or chronic pleural fluid accumulation, offering a less invasive, outpatient-based alternative to repeated thoracentesis or hospital-based procedures. These catheters, offer a less invasive and more patient-friendly alternative to repeated thoracentesis and hospital-based procedures, enabling outpatient and even home-based care. This shift toward minimally invasive and ambulatory care practices aligns with broader healthcare trends, including cost containment, reduced hospital stays, and improved patient comfort, which in turn expands the market potential for pleural drainage catheters.

Furthermore, ongoing advancements in catheter design such as smaller diameter catheters with better drainage efficiency, anti-microbial coatings, and integration with digital drainage systems are enhancing safety and clinical outcomes, further encouraging adoption. As a result, manufacturers are investing in expanding their pleural catheter product portfolios, targeting both developed and emerging markets. Collectively, the rising clinical demand, technological innovation, patient preference for less invasive care, and the expanding use of pleural drainage catheters in cancer and palliative care are making them a critical driver of growth in the overall chest drainage catheter market.

Given these trends, the pleural drainage catheters category is expected to generate substantial growth and significantly contribute to the overall expansion of the chest drainage catheters market throughout the forecast period of 2025 to 2032.

North America is expected to dominate the overall chest drainage catheters market:

North America is projected to hold the largest share of the chest drainage catheters market in 2024, driven by several key factors. This regional dominance is largely driven by a combination of demographic trends, clinical needs, and technological advancements that collectively contribute to strong market demand. A key growth factor is the increasing number of cancer patients, particularly those suffering from malignant pleural effusions, a condition commonly managed with chest drainage catheters. Additionally, the presence of key market players and a well-established healthcare infrastructure further solidify North America's position as the leading market for chest drainage catheters throughout the forecast period from 2025 to 2032.

For instance, according to GLOBOCAN (2024), the United States reported 226,033 cases of trachea, bronchus, and lung cancers, accounting for 87.9% of such cases in the region. Similarly, Canada recorded 31,157 cases in 2022. These cancers frequently lead to complications such as malignant pleural effusions, which require thoracic interventions involving chest drainage catheters for effective fluid management. As the prevalence of these conditions continues to rise, so does the need for reliable and efficient drainage systems, thereby propelling market growth.

Furthermore, the growing geriatric population in the U.S. is significantly contributing to market expansion. Older adults are more prone to developing both oncological conditions and chronic cardiopulmonary diseases, which often require thoracic interventions involving chest drainage systems. The increasing need for early diagnosis and timely intervention in managing fluid accumulation around the lungs and heart is propelling the adoption of chest drainage catheters across healthcare facilities.

Cardiovascular diseases are another key factor fueling demand. According to the Centers for Disease Control and Prevention (CDC, 2024), 1 in 20 adults aged 20 and older suffers from coronary heart disease in the U.S., and approximately 805,000 people experience heart attacks annually.

Many of these cases require post-surgical drainage or management of pericardial effusions, where chest drainage catheters are routinely employed to prevent complications and support recovery.

In addition, the supportive healthcare infrastructure, strong reimbursement policies, and the presence of key market players such as BD, Cook, and Teleflex Incorporated also position the region as a dominant contributor to the global chest drainage catheters market in the upcoming years.

Collectively, the aforementioned factors are expected to boost the market for chest drainage catheters in North America during the forecast period from 2025 to 2032.

Chest Drainage Catheters Market Key Players:

Some of the key market players operating in the chest drainage catheters market include BD, Teleflex Incorporated, Cook, ICU Medical, Redax S.p.A., Cardinal Health, Mediplus Ltd., Medela AG, Rocket Medical plc., Utah Medical Products, Inc., ANGIPLAST PRIVATE LIMITED, Vygon, Getinge AB, Poly Medicure Ltd., Sterimed Group, and others.

Recent Developmental Activities in the Chest Drainage Catheters Market:

• In June 2021, BD, a global leader in medical technology, announced that it received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its PeritX(TM) Peritoneal Catheter System. The device is intended for the drainage of symptomatic, recurrent non-malignant ascites, a debilitating condition characterized by the accumulation of fluid in the abdominal cavity.

Key takeaways from the chest drainage catheters market report study

• Market size analysis for current chest drainage catheters market size (2024), and market forecast for 8 years (2025 to 2032)
• Top key product/technology developments, mergers, acquisitions, partnerships, and joint ventures happened over the last 3 years.
• Key companies dominating the chest drainage catheters market.
• Various opportunities available for the other competitors in the chest drainage catheters market space.
• What are the top-performing segments in 2024? How these segments will perform in 2032?
• Which are the top-performing regions and countries in the current chest drainage catheters market scenario?
• Which are the regions and countries where companies should have concentrated on opportunities for chest drainage catheter market growth in the coming future?

Target audience who can benefit from this chest drainage catheters market report study

• Chest drainage catheter product providers
• Research organizations and consulting companies
• Chest drainage catheters-related organizations, associations, forums, and other alliances
• Government and corporate offices
• Start-up companies, venture capitalists, and private equity firms
• Distributors and traders dealing in chest drainage catheters
• Various end-users who want to know more about the chest drainage catheters market and the latest technological developments in the chest drainage catheters market.

Frequently Asked Questions for the Chest Drainage Catheters Market:

1. What are chest drainage catheters?

• Chest drainage catheters, also known as thoracic or pleural catheters, are flexible tubes inserted into the pleural space or mediastinum to remove air, fluid, blood, or pus from around the lungs or heart. They are essential in treating conditions such as pneumothorax, hemothorax, pleural effusion, and postoperative drainage following thoracic or cardiac surgery. These catheters help restore normal breathing mechanics, prevent lung collapse, and reduce the risk of infection or other complications. They are commonly used in emergency, surgical, and critical care settings.

2. What is the market for chest drainage catheters?

• The chest drainage catheters market is estimated to grow at a CAGR of 4.78% during the forecast period from 2025 to 2032.

3. What are the drivers for the chest drainage catheters market?

• The demand for chest drainage catheters is being driven by several critical factors, including the rising global prevalence of chronic conditions such as cancer, cardiovascular diseases, malignant pleural effusions, pneumothorax, hemothorax, and pericardial effusions, all of which frequently require thoracic drainage interventions. The growing burden of these conditions, along with advancements in catheter technology, increased healthcare access, and continued product innovation by key market players, is creating a supportive environment for market expansion. Collectively, these factors are propelling demand and reinforcing the critical role of chest drainage catheters in modern clinical care during the forecast period from 2025 to 2032

4. Who are the key players operating in the chest drainage catheters market?

• Some of the key market players operating in the chest drainage catheters market include BD, Teleflex Incorporated, Cook, ICU Medical, Redax S.p.A., Cardinal Health, Mediplus Ltd., Medela AG, Rocket Medical plc., Utah Medical Products, Inc., ANGIPLAST PRIVATE LIMITED, Vygon, Getinge AB, Poly Medicure Ltd., Sterimed Group, and others.

5. Which region has the highest share in the chest drainage catheters market?

• North America is projected to hold the largest share of the chest drainage catheters market in 2024, driven by several key factors. This regional dominance is largely driven by a combination of demographic trends, clinical needs, and technological advancements that collectively contribute to strong market demand. A key growth factor is the increasing number of cancer patients, particularly those suffering from malignant pleural effusions, a condition commonly managed with chest drainage catheters. Additionally, the presence of key market players and a well-established healthcare infrastructure further solidify North America's position as the leading market for chest drainage catheters throughout the forecast period from 2025 to 2032.